1. Home
  2. PRPO vs KDLY Comparison

PRPO vs KDLY Comparison

Compare PRPO & KDLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • KDLY
  • Stock Information
  • Founded
  • PRPO N/A
  • KDLY 2019
  • Country
  • PRPO United States
  • KDLY United States
  • Employees
  • PRPO N/A
  • KDLY N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • KDLY
  • Sector
  • PRPO Industrials
  • KDLY
  • Exchange
  • PRPO Nasdaq
  • KDLY NYSE
  • Market Cap
  • PRPO 9.9M
  • KDLY 7.8M
  • IPO Year
  • PRPO N/A
  • KDLY 2024
  • Fundamental
  • Price
  • PRPO $7.17
  • KDLY $1.40
  • Analyst Decision
  • PRPO
  • KDLY
  • Analyst Count
  • PRPO 0
  • KDLY 0
  • Target Price
  • PRPO N/A
  • KDLY N/A
  • AVG Volume (30 Days)
  • PRPO 6.7K
  • KDLY 43.7K
  • Earning Date
  • PRPO 03-28-2025
  • KDLY 02-18-2025
  • Dividend Yield
  • PRPO N/A
  • KDLY N/A
  • EPS Growth
  • PRPO N/A
  • KDLY N/A
  • EPS
  • PRPO N/A
  • KDLY N/A
  • Revenue
  • PRPO $17,411,000.00
  • KDLY $2,875,400.00
  • Revenue This Year
  • PRPO $75.18
  • KDLY N/A
  • Revenue Next Year
  • PRPO N/A
  • KDLY N/A
  • P/E Ratio
  • PRPO N/A
  • KDLY N/A
  • Revenue Growth
  • PRPO 31.31
  • KDLY N/A
  • 52 Week Low
  • PRPO $4.31
  • KDLY $0.65
  • 52 Week High
  • PRPO $7.20
  • KDLY $4.20
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 61.15
  • KDLY N/A
  • Support Level
  • PRPO $6.65
  • KDLY N/A
  • Resistance Level
  • PRPO $6.90
  • KDLY N/A
  • Average True Range (ATR)
  • PRPO 0.23
  • KDLY 0.00
  • MACD
  • PRPO 0.02
  • KDLY 0.00
  • Stochastic Oscillator
  • PRPO 84.72
  • KDLY 0.00

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Share on Social Networks: